The Effects of Pioglitazone in Reducing Atherosclerosis Progression and Neointima Volume in Type 2 Diabetic Patients: Prospective Randomized Study With Volumetric Intravascular Ultrasonography Analysis

BACKGROUND AND OBJECTIVES: Pioglitazone has been known for its anti-atherogenic effects. We compared the effects of pioglitazone in reducing atherosclerosis progression and neointima volume in type 2 diabetic patients. SUBJECTS AND METHODS: This was a prospective, randomized single-blinded, 8-month...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Sung Hye, Kim, Beum Suk, Hong, Soon Jun, Ahn, Chul-Min, Lim, Do-Sun
Formato: Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025335/
https://www.ncbi.nlm.nih.gov/pubmed/21267384
http://dx.doi.org/10.4070/kcj.2010.40.12.625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025335/
https://www.ncbi.nlm.nih.gov/pubmed/21267384
http://dx.doi.org/10.4070/kcj.2010.40.12.625

Ejemplares similares